Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity.
Deng W, Huang Y, Li H, Chen C, Lin Y, Wang M, Huang H, Liu T, Qin Q, Shao Y, Tang Y, Yuan K, Ding J, Xu L, Li Y, Zhang S.
Deng W, et al. Among authors: shao y.
Front Pharmacol. 2022 Sep 21;13:1015693. doi: 10.3389/fphar.2022.1015693. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36210855
Free PMC article.